Effect of Unilateral Intravitreal Bevacizumab on Contralateral Eye and Associated Factors in Patients with Diabetic Macular Edema at Kilimanjaro Christian Medical Centre
Samson Kitomary, Kelvin Rwegoshola, Sarah Kweka & Furahini Mndeme · Ophthalmology Research: An International Journal · 2026
Background: Diabetic macular edema being a foremost cause of visual loss in the diabetic population, is typically managed with intra-vitreal anti-VEGF therapy. The unilateral intra-vitreal bevacizumab (IVB) injections are standard, but the possible bilateral effect on the un-inje...
Open access
Research Article
10.9734/or/2026/v21i1497